Publications

Search or filter publications

Search publications Search

Filter by type:

Filter by publication type

• Book
• Book chapter
• Conference paper
• Journal article
• Other
• Patent
• Poster
• Report
• Scholarly edition
• Software
• Thesis dissertation
• Working paper

Filter by year:

Filter from 20262025202420232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995199419931992199119901989198819871986198519841983198219811980197919781977197619751974197319721971197019691968 to Filter to 20262025202420232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995199419931992199119901989198819871986198519841983198219811980197919781977197619751974197319721971197019691968

---

Search results

• Journal article
  Hay A, Barkoulas M, Tsiantis M, 2006,

  PINning down the connections: transcription factors and hormones in leaf morphogenesis (vol 9, pg 443, 2006)

  , CURRENT OPINION IN PLANT BIOLOGY, Vol: 9, Pages: 443-443, ISSN: 1369-5266
  • Author Web Link
  • Cite
  • Citations: 1
• Journal article
  Valdar W, Solberg LC, Gauguier D, Burnett S, Klenerman P, Cookson WO, Taylor MS, Rawlins JNP, Mott R, Flint Jet al., 2006,

  Genome-wide genetic association of complex traits in heterogeneous stock mice.

  , Nat Genet, Vol: 38, Pages: 879-887, ISSN: 1061-4036

  Difficulties in fine-mapping quantitative trait loci (QTLs) are a major impediment to progress in the molecular dissection of complex traits in mice. Here we show that genome-wide high-resolution mapping of multiple phenotypes can be achieved using a stock of genetically heterogeneous mice. We developed a conservative and robust bootstrap analysis to map 843 QTLs with an average 95% confidence interval of 2.8 Mb. The QTLs contribute to variation in 97 traits, including models of human disease (asthma, type 2 diabetes mellitus, obesity and anxiety) as well as immunological, biochemical and hematological phenotypes. The genetic architecture of almost all phenotypes was complex, with many loci each contributing a small proportion to the total variance. Our data set, freely available at http://gscan.well.ox.ac.uk, provides an entry point to the functional characterization of genes involved in many complex traits.

  • Abstract
  • Author Web Link
  • Cite
• Journal article
  Cookson WOC, 2006,

  State of the art. Genetics and genomics of chronic obstructive pulmonary disease.

  , Proc Am Thorac Soc, Vol: 3, Pages: 473-475, ISSN: 1546-3222
  • Author Web Link
  • Cite
• Conference paper
  Morar N, Harper J, Cookson WO, Moffatt MFet al., 2006,

  Filaggrin mutations in atopic dermatitis

  , 36th Annual Meeting of the European-Society-of-Dermatology-Research (ESDR), Publisher: NATURE PUBLISHING GROUP, Pages: 38-38, ISSN: 0022-202X
  • Author Web Link
  • Cite
• Journal article
  Lau QC, Raja E, Salto-Tellez M, Liu Q, Ito K, Inoue M, Putti TC, Loh M, Ko TK, Huang C, Bhalla KN, Zhu T, Ito Y, Sukumar Set al., 2006,

  RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer.

  , Cancer Res, Vol: 66, Pages: 6512-6520, ISSN: 0008-5472

  A tumor suppressor function has been attributed to RUNX3, a member of the RUNX family of transcription factors. Here, we examined alterations in the expression of three members, RUNX1, RUNX2, and RUNX3, and their interacting partner, CBF-beta, in breast cancer. Among them, RUNX3 was consistently underexpressed in breast cancer cell lines and primary tumors. Fifty percent of the breast cancer cell lines (n = 19) showed hypermethylation at the promoter region and displayed significantly lower levels of RUNX3 mRNA expression (P < 0.0001) and protein (P < 0.001). In primary Singaporean breast cancers, 9 of 44 specimens showed undetectable levels of RUNX3 by immunohistochemistry. In 35 of 44 tumors, however, low levels of RUNX3 protein were present. Remarkably, in each case, protein was mislocalized to the cytoplasm. In primary tumors, hypermethylation of RUNX3 was observed in 23 of 44 cases (52%) and was undetectable in matched adjacent normal breast epithelium. Mislocalization of the protein, with or without methylation, seems to account for RUNX3 inactivation in the vast majority of the tumors. In in vitro and in vivo assays, RUNX3 behaved as a growth suppressor in breast cancer cells. Stable expression of RUNX3 in MDA-MB-231 breast cancer cells led to a more cuboidal phenotype, significantly reduced invasiveness in Matrigel invasion assays, and suppressed tumor formation in immunodeficient mice. This study provides biological and mechanistic insights into RUNX3 as the key member of the family that plays a role in breast cancer. Frequent protein mislocalization and methylation could render RUNX3 a valuable marker for early detection and risk assessment.

  • Abstract
  • Author Web Link
  • Cite
• Journal article
  Griesenbach U, Geddes DM, Alton EWFW, 2006,

  Gene therapy progress and prospects: cystic fibrosis

  , GENE THERAPY, Vol: 13, Pages: 1061-1067, ISSN: 0969-7128
  • Author Web Link
  • Cite
  • Citations: 72
• Journal article
  Morar N, Willis-Owen SAG, Moffatt MF, Cookson WOCMet al., 2006,

  The genetics of atopic dermatitis

  , JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, Vol: 118, Pages: 24-34, ISSN: 0091-6749
  • Author Web Link
  • Cite
  • Citations: 194
• Conference paper
  Garvey JP, Chotirmall SH, Dorman A, Walshe Jet al., 2006,

  Co-trimoxazole induced acute interstitial nephritis in renal allografts: Clinical course and outcome

  , 43rd Annual Congress of the European-Renal-Association/European-Dialysis-and-Transplant-Association (ERA-EDTA), Publisher: OXFORD UNIV PRESS, Pages: 523-523, ISSN: 0931-0509
  • Cite
• Journal article
  Reed A, Snell GI, McLean C, Williams TJet al., 2006,

  Outcomes of patients with interstitial lung disease referred for lung transplant assessment.

  , Intern Med J, Vol: 36, Pages: 423-430

  BACKGROUND: Patients with interstitial lung disease (ILD) very frequently die before the opportunity to receive lung transplantation (LTx). This retrospective study describes the clinical course of 86 patients with ILD referred for LTx assessment between January 1999 and December 2002. AIMS: (i) To describe the outcomes, (ii) to identify reasons of delay to transplantation, (iii) to describe the causes of death/complications and (iv) to assess the pathological diagnosis and concordance with explanted lung pathology. METHODS: Data were collected from the case notes of all patients with ILD referred to the Alfred Hospital over a 4-year period. RESULTS: Twenty women and 66 men, mean age of 55 +/- 8 years, were referred for LTx assessment. Forty-five patients were deemed not suitable for LTx and 41 were listed. Twenty-two patients underwent transplantation, 16 died on the waiting list and 7 are still on the waiting list. Complications were frequent (e.g. pulmonary embolism, malignancy and infection) and carried high mortality. Patients dying on the waiting list appeared generally to be in accelerated decline, dying shortly after listing, with no evidence in their lung function test assessment predicting them as a poor prognosis group. CONCLUSIONS: Serious complications and death on the waiting list of patients with idiopathic pulmonary fibrosis are high, not apparently because of delayed referral but usually in patients undergoing very rapid decline.

  • Abstract
  • Author Web Link
  • Cite
• Conference paper
  Garvey JP, Chotirmall SH, Curran S, Conlon P, Donohoe J, Walshe Jet al., 2006,

  Sirolimus in chronic allograft nephropathy

  , 43rd Annual Congress of the European-Renal-Association/European-Dialysis-and-Transplant-Association (ERA-EDTA), Publisher: OXFORD UNIV PRESS, Pages: 268-268, ISSN: 0931-0509
  • Cite

This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.